Management of Allergic Skin Reaction After Initial Diphenhydramine Dose
For an allergic skin reaction of unknown cause that has not responded to an initial 25 mg dose of diphenhydramine, epinephrine should be administered as the first-line treatment, not additional antihistamines, especially if there are any signs of progression beyond simple cutaneous symptoms. 1
Assessment of Severity and Progression
- Evaluate for signs of anaphylaxis beyond skin symptoms, including respiratory symptoms (stridor, wheezing, dyspnea), cardiovascular symptoms (hypotension, tachycardia), or gastrointestinal symptoms (vomiting, abdominal pain) 1
- If the reaction remains limited to cutaneous manifestations (urticaria, flushing, mild angioedema) without progression, additional antihistamine therapy may be considered 1
- Any signs of progression beyond mild cutaneous symptoms should prompt immediate epinephrine administration 1
Treatment Algorithm
For Mild Reactions (Cutaneous Only)
- If symptoms are limited to urticaria, flushing, or mild angioedema without progression:
For Progressive or Severe Reactions
- If any signs of progression beyond cutaneous symptoms or severe symptoms:
- Administer epinephrine immediately (0.3-0.5 mg IM in adults) in the anterolateral thigh 1
- Do not delay epinephrine administration by giving additional antihistamines first 1
- Place patient in supine position if cardiovascular symptoms are present 1
- Monitor vital signs continuously 1
- Prepare for possible need of repeated epinephrine doses (every 5-15 minutes if symptoms persist) 1
Important Considerations
Antihistamines should never be used alone to treat anaphylaxis or progressive allergic reactions as they:
Biphasic reactions (recurrence after initial improvement) can occur:
Potential Adverse Effects of Additional Diphenhydramine
- Rapid IV administration or excessive doses of diphenhydramine can cause:
Follow-up Plan
- If treated for anaphylaxis, provide:
Remember that early administration of epinephrine for progressive allergic reactions is associated with better outcomes in terms of morbidity and mortality, while delays in epinephrine administration are associated with poorer outcomes 1.